Call Options

5 transactions
Quarter Operation Price Per call calls change calls Held SEC Form
Q1 2021

May 17, 2021

SELL
$15.82 - $22.11 $711,900 - $994,950
-45,000 Closed
0 $0
Q4 2020

Feb 16, 2021

BUY
$7.91 - $22.95 $355,950 - $1.03 Million
45,000 New
45,000 $933,000
Q2 2020

Aug 14, 2020

SELL
$4.67 - $8.95 $233,500 - $447,499
-50,000 Closed
0 $0
Q1 2020

May 15, 2020

BUY
$3.95 - $7.4 $164,320 - $307,840
41,600 Added 495.24%
50,000 $248,000
Q3 2019

Nov 14, 2019

BUY
$3.04 - $5.32 $25,536 - $44,688
8,400 New
8,400 $26,000

Others Institutions Holding OCUL

About OCULAR THERAPEUTIX, INC


  • Ticker OCUL
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 76,966,896
  • Market Cap $764M
  • Description
  • Ocular Therapeutix, Inc., a biopharmaceutical company, focuses on the formulation, development, and commercialization of therapies for diseases and conditions of the eye using its bioresorbable hydrogel-based formulation technology. The company markets ReSure Sealant, an ophthalmic device to prevent wound leaks in corneal incisions following cat...
More about OCUL
Track This Portfolio

Track Caption Management, LLC Portfolio

Follow Caption Management, LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Caption Management, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Caption Management, LLC with notifications on news.